Corbus Pharmaceuticals Holdings Inc. Company Profile
NASDAQ: CRBPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 5.50 +2.23%
Corbus Pharmaceuticals at a glance
Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Norwood, MA. Corbus Pharmaceuticals is led by Dr. Yuval Cohen Ph.D. and employs about 36 people. At a market capitalization of $101.9 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001595097, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Corbus Pharmaceuticals do?
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- Corbus Pharmaceuticals Holdings Inc.
- Ticker
- NASDAQ: CRBP
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. Yuval Cohen Ph.D.
- Employees
- 36
- Headquarters
- 500 River Ridge Drive, Norwood, MA, United States
- Phone
- 617 963 0100
- Website
- corbuspharma.com
- Market cap
- $101.93M
- SEC CIK
- 0001595097
- Latest annual report
- 10-K · Mar 9, 2026
Companies similar to Corbus Pharmaceuticals
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KZIAKazia Therapeutics Limited ADR | 8.93 | +1.25% | $102.04M | vs CRBP |
| BMEABiomea Fusion Inc. | 1.42 | +3.65% | $102.67M | vs CRBP |
| ANIXAnixa Biosciences Inc. | 2.90 | -0.34% | $100.82M | vs CRBP |
| PDSBPDS Biotechnology Corporation | 1.38 | +35.29% | $100.01M | vs CRBP |
| PLYXPolaryx Therapeutics Inc. | 2.00 | 0.00% | $99.69M | vs CRBP |
| AARDAardvark Therapeutics Inc. | 4.76 | +1.06% | $104.17M | vs CRBP |
| CPIXCumberland Pharmaceuticals Inc. | 7.03 | +0.72% | $105.33M | vs CRBP |
| OKUROnKure Therapeutics Inc. Class A | 2.41 | +4.78% | $97.60M | vs CRBP |